Alternatively, you can fill out our online contact form , and we will get in touch with you as soon as possible.
Patients should confirm the exact medication, pharmacy, formulation, regulatory status, and provider oversight before beginning any protocol
The metabolic profiling revealed that AOD9604 undergoes rapid proteolytic degradation in serum, generating a series of predictable fragment peptides
Steps to apply for the Novo Nordisk Patient Assistance Program Confirm eligibility: Check if you meet the programs income and insurance residency requirements
Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
Recalls & Warnings June 26, 2024 FDA Warns Consumers Not to Use Infla-650 Due to Undeclared Drugs On June 20, 2024, the FDA warned consumers not to purchase or use Infla-650 after FDA laboratory analysis found them to contain acetaminophen, diclofenac, and phenylbutazone